Abstract
Age- related neurodegenerative diseases, especially Alzheimers disease (AD), are an important health problem globally. AD is clinically characterized by loss of memory, reasoning and speech. The frequency of the disease reaches to 20-40% in the population over the age of 85. Autopsy findings have indicated the presence of senile plaques and neurofibrillary tangles in the brains of patients with AD. These two lesions can be seen in small numbers during normal aging of the brain but occur in large amounts during AD. Although the initiating causes leading to AD are unknown, oxidative damage appears to play an important role in the slowly progressive neuronal death that is characteristic of AD. Indeed, in addition to the presence of senile plaques and neurofibrillary tangles, postmortem analysis of AD brain has also identified markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidation products and oxidized DNA bases. This review discusses the role of reactive oxygen and nitrogen species in the pathogenesis of AD and examines the relevance of antioxidant therapy in altering and / or inhibiting neurodegeneration associated with the disease.
Keywords: alzheimers disease, oxidative stress, reactive oxygen species, antioxidant
Current Alzheimer Research
Title: Reactive Oxygen and Nitrogen Species in Alzheimers Disease
Volume: 1 Issue: 2
Author(s): Mutay Aslan and Tomris Ozben
Affiliation:
Keywords: alzheimers disease, oxidative stress, reactive oxygen species, antioxidant
Abstract: Age- related neurodegenerative diseases, especially Alzheimers disease (AD), are an important health problem globally. AD is clinically characterized by loss of memory, reasoning and speech. The frequency of the disease reaches to 20-40% in the population over the age of 85. Autopsy findings have indicated the presence of senile plaques and neurofibrillary tangles in the brains of patients with AD. These two lesions can be seen in small numbers during normal aging of the brain but occur in large amounts during AD. Although the initiating causes leading to AD are unknown, oxidative damage appears to play an important role in the slowly progressive neuronal death that is characteristic of AD. Indeed, in addition to the presence of senile plaques and neurofibrillary tangles, postmortem analysis of AD brain has also identified markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidation products and oxidized DNA bases. This review discusses the role of reactive oxygen and nitrogen species in the pathogenesis of AD and examines the relevance of antioxidant therapy in altering and / or inhibiting neurodegeneration associated with the disease.
Export Options
About this article
Cite this article as:
Aslan Mutay and Ozben Tomris, Reactive Oxygen and Nitrogen Species in Alzheimers Disease, Current Alzheimer Research 2004; 1 (2) . https://dx.doi.org/10.2174/1567205043332162
DOI https://dx.doi.org/10.2174/1567205043332162 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Pharmacokinetic and Toxicological Characteristics of Tripterigium Glycosides and Their Derivatives
Current Drug Metabolism The Location of Vascular Flap is Related with Daily Activity Patterns in Non-traumatic Acute Aortic Syndrome in a Chinese Population
Current Signal Transduction Therapy Crosstalk Between the Autophagy-Lysosome Pathway and the Ubiquitin-Proteasome Pathway in Retinal Pigment Epithelial Cells
Current Molecular Medicine Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary)
CNS & Neurological Disorders - Drug Targets Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Multiscale Molecular Dynamics of Protein Aggregation
Current Protein & Peptide Science In Silico Studies Most Employed in the Discovery of New Antimicrobial Agents
Current Medicinal Chemistry Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Current Pharmaceutical Design The Interaction of Zinc Oxide/Green Tea Extract Complex Nanoparticles and its Effect on Monosodium Glutamate Toxicity in Liver of Rats
Current Pharmaceutical Biotechnology Mossy Fiber Sprouting as a Potential Therapeutic Target for Epilepsy
Current Neurovascular Research Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer Research Small Molecules as Anti-TNF Drugs
Current Medicinal Chemistry Chemical Exchange Saturation Transfer (CEST) Imaging of pH
Neuroscience and Biomedical Engineering (Discontinued) Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
Current Medicinal Chemistry CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Perspectives in Psychopharmacological Neuroimaging (Executive Editor: Paolo Fusar-Poli)]
Current Pharmaceutical Design Dietary Assumption of Plant Polyphenols and Prevention of Allergy
Current Pharmaceutical Design Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer’s Disease Mice Model
Current Alzheimer Research Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?
Current Clinical Pharmacology